ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Henrik Jönsson
Per Johnsson
Stephen Westaby
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jönsson, H.
Right arrow Articles by Blomquist, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jönsson, H.
Right arrow Articles by Blomquist, S.

Ann Thorac Surg 1998;65:1639-1644
© 1998 The Society of Thoracic Surgeons


Original articles: cardiovascular

Significance of Serum S100 Release After Coronary Artery Bypass Grafting

Henrik Jönsson, MDa, Per Johnsson, MD, PhDa, Christer Alling, MD, PhDa, Stephen Westaby, FRCSa, Sten Blomquist, MD, PhDa

a Division of Cardiothoracic Surgery, Department of Heart-Lung Diseases, University Hospital MAS, Malmö, Sweden

Accepted for publication January 26, 1998.

Address reprint requests to Dr Johnsson, Division of Cardiothoracic Surgery, Lund University Hospital, SE-221 85 Lund, Sweden
e-mail: (pelle.johnsson{at}medforsk.mas.lu.se)

Background. S100 protein has been suggested to be a serum marker for cerebral complications after cardiac operation and extracorporeal circulation. The aim of this study was to characterize the S100 release pattern after extracorporeal circulation in 515 consecutive patients undergoing coronary artery bypass grafting.

Methods. Clinical variables and outcome were prospectively registered. The cerebral outcome was determined by clinical examination. S100 was measured at the end of extracorporeal circulation, and after 5, 15, and 48 hours.

Results. After operation, 13 patients had stroke, 12 had delayed awakening, and 17 had encephalopathy. Early S100 release, immediately after extracorporeal circulation, was associated with age and perfusion time, but not with cerebral outcome. However, S100 release after 5 to 48 hours was associated with cerebral complications and risk factors for such outcome. Patients with stroke had higher S100 levels after 15 to 48 hours. A subset of patients with renal failure had overall higher S100 levels at 5 hours.

Conclusions. Early and late S100 release indicate different mechanisms for release and emphasizes the potential power of this new biochemical marker for cerebral damage.




This article has been cited by other articles:


Home page
PerfusionHome page
P. D Raymond, M. Radel, M. J Ray, A. D Hinton-Bayre, and N. A Marsh
Investigation of factors relating to neuropsychological change following cardiac surgery.
Perfusion, January 1, 2007; 22(1): 27 - 33.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Dogan, T. Aybek, P. S. Risteski, F. Detho, A. Rapp, G. Wimmer-Greinecker, and A. Moritz
Minimally Invasive Port Access Versus Conventional Mitral Valve Surgery: Prospective Randomized Study
Ann. Thorac. Surg., February 1, 2005; 79(2): 492 - 498.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Iriz, F. Kolbakir, H. Akar, B. Adam, and H. T. Keceligil
Comparison of Hydroxyethyl Starch and Ringer Lactate as a Prime Solution Regarding S-100{beta} Protein Levels and Informative Cognitive Tests in Cerebral Injury
Ann. Thorac. Surg., February 1, 2005; 79(2): 666 - 671.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
R. I. Hall
Serum S-100{beta} protein and postoperative neurological dysfunction - ready for prime time?/La proteine serique S-100{beta} et la dysfonction neurologique postoperatoire - correlation prete pour une large diffusion?
Can J Anesth, August 1, 2004; 51(7): 645 - 648.
[Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
M. Kanbak, F. Saricaoglu, A. Avci, T. Ocal, Z. Koray, and U. Aypar
Propofol offers no advantage over isoflurane anesthesia for cerebral protection during cardiopulmonary bypass: a preliminary study of S-100{beta} protein levels: [L'anesthesie au propofol, compare a l'isoflurane, n'a pas d'avantage pour la protection cerebrale pendant la circulation extracorporelle : une etude preliminaire des niveaux de proteines S-100{beta}]
Can J Anesth, August 1, 2004; 51(7): 712 - 717.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. Fazio, S. K. Bhudia, N. Marchi, B. Aumayr, and D. Janigro
Peripheral detection of S100{beta} during cardiothoracic surgery: what are we really measuring?
Ann. Thorac. Surg., July 1, 2004; 78(1): 46 - 52.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. R. Lynch, R. Blessing, W. D. White, H. P. Grocott, M. F. Newman, and D. T. Laskowitz
Novel Diagnostic Test for Acute Stroke
Stroke, January 1, 2004; 35(1): 57 - 63.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Ueno, Y. Iguro, H. Yamamoto, R. Sakata, Y. Kakihana, and K. Nakamura
Serial measurement of serum S-100B protein as a marker of cerebral damage after cardiac surgery
Ann. Thorac. Surg., June 1, 2003; 75(6): 1892 - 1897.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Marchi, V. Fazio, L. Cucullo, K. Kight, T. Masaryk, G. Barnett, M. Volgelbaum, M. Kinter, P. Rasmussen, M. R. Mayberg, et al.
Serum Transthyretin Monomer as a Possible Marker of Blood-to-CSF Barrier Disruption
J. Neurosci., March 1, 2003; 23(5): 1949 - 1955.
[Abstract] [Full Text] [PDF]


Home page
Behav ModifHome page
C. K. Haddock, W. S. C. Poston, and J. E. Taylor
Neurocognitive Sequelae Following Coronary Artery Bypass Graft: A Research Agenda for Behavioral Scientists
Behav Modif, January 1, 2003; 27(1): 68 - 82.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Dogan, K. Graubitz, T. Aybek, M. F. Khan, P. Kessler, A. Moritz, and G. Wimmer-Greinecker
How safe is the port access technique in minimally invasive coronary artery bypass grafting?
Ann. Thorac. Surg., November 1, 2002; 74(5): 1537 - 1543.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
M. A. Ozatik, O. Tarcan, A. Kale, G. Askon, M. Balco, A. Undar, D. S. Kucukaksu, E. Sener, and O. Tasdemir
Do S100{beta} protein level increases due to inflammation during cardiopulmonary bypass occur without any neurological deficit?
Perfusion, September 1, 2002; 17(5): 335 - 338.
[Abstract] [PDF]


Home page
PerfusionHome page
R. Ascione, S. Al-Ruzzeh, K. Amer, and G. D Angelini
Subsystem organ function during coronary surgery
Perfusion, July 1, 2002; 17(4): 295 - 303.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. S. Aldea, L. O. Soltow, W. L. Chandler, C. M. Triggs, C. R. Vocelka, G. I. Crockett, Y. T. Shin, W. E. Curtis, and E. D. Verrier
Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits
J. Thorac. Cardiovasc. Surg., April 1, 2002; 123(4): 742 - 755.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
R I. Johnson, M. A Fox, A. Grayson, M. Jackson, and B. M Fabri
Should we rely on nasopharyngeal temperature during cardiopulmonary bypass?
Perfusion, March 1, 2002; 17(2): 145 - 151.
[Abstract] [PDF]


Home page
CVIHome page
L. V. C. Portela, J. C. T. Brenol, R. Walz, M. Bianchin, A. B. L. Tort, U. P. Canabarro, S. Beheregaray, J. A. Marasca, R. M. Xavier, E. C. Neto, et al.
Serum S100B Levels in Patients with Lupus Erythematosus: Preliminary Observation
Clin. Vaccine Immunol., January 1, 2002; 9(1): 164 - 166.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. W. Bottiger, S. Mobes, R. Glatzer, H. Bauer, A. Gries, P. Bartsch, J. Motsch, and E. Martin
Astroglial Protein S-100 Is an Early and Sensitive Marker of Hypoxic Brain Damage and Outcome After Cardiac Arrest in Humans
Circulation, June 5, 2001; 103(22): 2694 - 2698.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. A. LeMaire, J. K. Bhama, Z. C. Schmittling, P. J. Oberwalder, C. Koksoy, S. A. Raskin, P. E. Curling, and J. S. Coselli
S100{beta} correlates with neurologic complications after aortic operation using circulatory arrest
Ann. Thorac. Surg., June 1, 2001; 71(6): 1913 - 1919.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Kislinger, N. Tanji, T. Wendt, W. Qu, Y. Lu, L. J. Ferran Jr, A. Taguchi, K. Olson, L. Bucciarelli, M. Goova, et al.
Receptor for Advanced Glycation End Products Mediates Inflammation and Enhanced Expression of Tissue Factor in Vasculature of Diabetic Apolipoprotein E-Null Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 905 - 910.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Jonsson, P. Johnsson, M. Birch-Iensen, C. Alling, S. Westaby, and S. Blomquist
S100B as a predictor of size and outcome of stroke after cardiac surgery
Ann. Thorac. Surg., May 1, 2001; 71(5): 1433 - 1437.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Svenmarker, E. Sandstrom, T. Karlsson, S. Haggmark, E. Jansson, M. Appelblad, R. Lindholm, and T. Aberg
Neurological and general outcome in low-risk coronary artery bypass patients using heparin coated circuits
Eur. J. Cardiothorac. Surg., January 1, 2001; 19(1): 47 - 53.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Herrmann, P. Vos, M. T. Wunderlich, C. H. M. M. de Bruijn, and K. J. B. Lamers
Release of Glial Tissue-Specific Proteins After Acute Stroke : A Comparative Analysis of Serum Concentrations of Protein S-100B and Glial Fibrillary Acidic Protein
Stroke, November 1, 2000; 31(11): 2670 - 2677.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Masetti and N. T. Kouchoukos
S-100{beta} protein: Yet uncertain role as a marker of cerebral injury in cardiac surgery
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 830 - 831.
[Full Text]


Home page
Br J AnaesthHome page
M. S. Ali, M. Harmer, and R. Vaughan
Serum S100 protein as a marker of cerebral damage during cardiac surgery
Br. J. Anaesth., August 1, 2000; 85(2): 287 - 298.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Herrmann, A. D. Ebert, I. Galazky, M. T. Wunderlich, W. S. Kunz, and C. Huth
Neurobehavioral Outcome Prediction After Cardiac Surgery : Role of Neurobiochemical Markers of Damage to Neuronal and Glial Brain Tissue
Stroke, March 1, 2000; 31(3): 645 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Westaby, K. Saatvedt, S. White, T. Katsumata, W. van Oeveren, N. K. Bhatnagar, S. Brown, and P. W. Halligan
IS THERE A RELATIONSHIP BETWEEN SERUM S-100{beta} PROTEIN AND NEUROPSYCHOLOGIC DYSFUNCTION AFTER CARDIOPULMONARY BYPASS?
J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 132 - 137.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Jonsson, P. Johnsson, C. Alling, M. Backstrom, C. Bergh, and S. Blomquist
S100{beta} after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome
Ann. Thorac. Surg., December 1, 1999; 68(6): 2202 - 2208.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.